Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease.

Nuij, V J A A

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease. [electronic resource] - Journal of translational medicine 12 2017 - 248 p. digital

Publication Type: Journal Article

1479-5876

10.1186/s12967-017-1355-9 doi


Adalimumab--therapeutic use
Adolescent
Adult
Aged
Autophagy-Related Proteins--genetics
Child
Child, Preschool
Female
Gene Frequency--genetics
Genetic Association Studies
Genetic Predisposition to Disease
Humans
Inflammatory Bowel Diseases--drug therapy
Logistic Models
Male
Middle Aged
Polymorphism, Single Nucleotide--genetics
Young Adult